1. Home
  2. NTWK vs ATRA Comparison

NTWK vs ATRA Comparison

Compare NTWK & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$3.41

Market Cap

39.7M

Sector

Technology

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$4.84

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTWK
ATRA
Founded
1997
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.7M
38.9M
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
NTWK
ATRA
Price
$3.41
$4.84
Analyst Decision
Sell
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
12.7K
56.8K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
316.67
122.52
EPS
N/A
2.57
Revenue
$73,088,687.00
$120,772,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.91
Revenue Growth
13.40
N/A
52 Week Low
$2.34
$3.92
52 Week High
$5.75
$19.15

Technical Indicators

Market Signals
Indicator
NTWK
ATRA
Relative Strength Index (RSI) 50.17 47.21
Support Level $3.22 $4.22
Resistance Level $3.69 $5.47
Average True Range (ATR) 0.13 0.33
MACD -0.01 -0.01
Stochastic Oscillator 39.33 33.59

Price Performance

Historical Comparison
NTWK
ATRA

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Share on Social Networks: